Cencora Inc
Research Cencora Inc (COR) on Bullrun: valuation model: 22.5% overvalued, market cap USD 62.60B, P/E 24.4, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCOR
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyUSD
- Valuation signal22.5% overvalued
- Market capUSD 62.60B
- P/E24.4
- Dividend yield0.8%
- Financial periodQ2 2026
- RevenueUSD 84.75B
- Net incomeUSD 763.52M
- Free cash flowUSD 2.43B
- Gross margin4.3%
Valuation Snapshot
Bullrun's latest valuation model marks Cencora Inc as 22.5% overvalued; latest market cap is USD 62.60B; P/E is 24.4; dividend yield is 0.8%.
Peer valuation comparison
Latest P/E is 24.39x versus a Healthcare sector median of 24.46x.
Latest dividend yield is 0.75% versus a Healthcare sector median of 2.11% (64.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 321.33B | USD 1.55B | USD 3.21B | 3.6% | 7.96 | USD 4.36B | USD 7.66B | USD 1.51B |
| FY2024 | USD 293.96B | USD 1.51B | USD 3.00B | 3.4% | 7.53 | USD 3.13B | USD 4.39B | USD 645.94M |
| FY2023 | USD 262.17B | USD 1.75B | USD 3.45B | 3.4% | 8.53 | USD 2.59B | USD 4.79B | USD 522.00M |
| FY2022 | USD 238.59B | USD 1.70B | USD 2.21B | 3.5% | 8.04 | USD 3.39B | USD 5.70B | -USD 211.56M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 62.60B | 24.4 | 0.7% | 2.4 |
| 2025 | 2025-12-31 | USD 65.70B | 40.6 | 0.7% | 2.25 |
| 2024 | 2024-12-31 | USD 43.55B | 32.0 | 0.9% | 2.08 |
| 2023 | 2023-12-29 | USD 41.02B | 24.1 | 1.0% | 1.98 |
| 2022 | 2022-12-30 | USD 33.49B | 20.6 | 1.1% | 1.87 |
| 2021 | 2021-12-31 | USD 27.78B | 17.3 | 1.3% | 1.78 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.4 USD, yield 0.8%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.2 USD |
| FY2024 | 2.04 USD |
| FY2023 | 1.94 USD |
| FY2022 | 1.84 USD |
About Cencora Inc
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Cencora Inc overvalued or undervalued?
Bullrun's valuation model currently marks Cencora Inc as 22.5% overvalued.
What is Cencora Inc's market cap?
Cencora Inc's market capitalization is USD 62.60B.
What is Cencora Inc's P/E ratio?
Cencora Inc's price-to-earnings (P/E) ratio is 24.4.
Does Cencora Inc pay a dividend?
Cencora Inc has a dividend yield of 0.8%.
What does Cencora Inc do?
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S.